Director/PDMR Shareholding

Hikma Pharmaceuticals Plc

13 March 2024

 

Hikma Pharmaceuticals PLC - EIP Vesting

LONDON, 13 March 2024: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards which were granted on 25 February 2022 under the 2014 Executive Incentive Plan ("EIP") Element B and 25 February 2021 under the EIP Element C.

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Said Darwazah
2	Reason for the notification
a)	Position/status	Executive Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards under the EIP Element B and EIP Element C.  All Shares were retained.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	EIP Award, Element B: 34,652
		Nil	EIP Award, Element C: 19,830
d)	Aggregated information	Price(s): nil Volume(s): 54,482
e)	Date of the transaction	12 March 2024
f)	Place of the transaction	London Stock Exchange (XLON)

Riad Mishlawi

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Riad Mishlawi
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares)  ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards under the EIP Element B and EIP Element C.  All Shares were retained.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	EIP Award, Element B: 22,099
		Nil	EIP Award, Element C: 17,120
d)	Aggregated information	Price(s): nil Volume(s): 39,219
e)	Date of the transaction	12 March 2024
f)	Place of the transaction	London Stock Exchange (XLON)

Mazen Darwazah

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mazen Darwazah
2	Reason for the notification
a)	Position/status	Executive Vice Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards under the EIP Element B and EIP Element C.  All Shares were retained.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	EIP Award, Element B: 26,812
		Nil	EIP Award, Element C: 13,903
d)	Aggregated information	Price(s): nil Volume(s): 40,715
e)	Date of the transaction	12 March 2024
f)	Place of the transaction	London Stock Exchange (XLON)

Khalid Nabilsi

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Khalid Nabilsi
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards under the EIP Element B and EIP Element C. All Shares were retained.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	EIP Award, Element B: 20,643
		Nil	EIP Award, Element C: 13,927
d)	Aggregated information	Price(s): nil Volume(s): 34,570
e)	Date of the transaction	12 March 2024
f)	Place of the transaction	London Stock Exchange (XLON)

Brian Hoffmann

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Brian Hoffmann
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards under the EIP Element B and EIP Element C.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	EIP Award, Element B: 14,663
		Nil	EIP Award, Element C: 10,227
d)	Aggregated information	Price(s): nil Volume(s): 24,890
e)	Date of the transaction	12 March 2024
f)	Place of the transaction	London Stock Exchange (XLON)
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares sold to cover tax following the vesting of conditional awards under the EIP Element B and EIP Element C.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		£18.942	EIP Award, Element B: 5,471
		£18.942	EIP Award, Element C: 3,816
d)	Aggregated information	Price(s): £18.942 Volume(s): 9,287 Total(s): £175,916.51
e)	Date of the transaction	12 March 2024
f)	Place of the transaction	London Stock Exchange (XLON)

Susan Ringdal

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Susan Ringdal
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards under the EIP Element B and EIP Element C.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	EIP Award, Element B: 11,072
		Nil	EIP Award, Element C: 6,812
d)	Aggregated information	Price(s): nil Volume(s): 17,844
e)	Date of the transaction	12 March 2024
f)	Place of the transaction	London Stock Exchange (XLON)
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares sold to cover tax following the vesting of conditional awards under the EIP Element B and EIP Element C.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		£18.942	EIP Award, Element B: 5,109
		£18.942	EIP Award, Element C: 3,144
d)	Aggregated information	Price(s): £18.942 Volume(s): 8,253 Total(s): £156,330.24
e)	Date of the transaction	12 March 2024
f)	Place of the transaction	London Stock Exchange (XLON)

Hussein Arkhagha

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Hussein Arkhagha
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards under the EIP Element B and EIP Element C.  All Shares were retained.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	EIP Award, Element B: 10,598
		Nil	EIP Award, Element C: 5,245
d)	Aggregated information	Price(s): nil Volume(s): 15,843
e)	Date of the transaction	12 March 2024
f)	Place of the transaction	London Stock Exchange (XLON)

Helen Middlemist
Group Company Secretary

[phone]

13 March 2024

 

END